🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Status
Suspended
Location
Mayo Clinic in Rochester
Start Date
2024-05-03
Trial ID
NCT06200103
This phase I trial tests the safety and tolerability of olaparib in combina...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2023-05-22
Trial ID
NCT05411094
RATIONALE: Screening may help doctors find colorectal cancer sooner, when i...
Status
Completed
Location
Harvard Medical School
Start Date
2005-03
Trial ID
NCT00355004
Treatments Being Tested
This phase I trial is studying the safety, side effects, and best dose of g...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2024-07-25
Trial ID
NCT06225427
This phase I/II trial identifies the best dose and side effects of selinexo...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2021-05-06
Trial ID
NCT04764942
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This phase I/Ib trial is to find out the best dose, possible benefits and/o...
Status
Suspended
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2022-02-02
Trial ID
NCT04840589
This phase II trial studies how well the combination of botensilimab, balst...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06575725
This clinical trial evaluates the usefulness of using a smartphone-based HI...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2023-03-22
Trial ID
NCT04949464
Treatments Being Tested
This phase I/II trial tests the safety, side effects and effectiveness of r...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-12-26
Trial ID
NCT06432036